« Previous
Next »
The Journal of Pediatrics
Volume 150, Issue 2
, Pages 146-150.e2
, February 2007
Longitudinal Lipid Screening and Use of Lipid-Lowering Medications in Pediatric Type 1 Diabetes
References
- Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003;26:2194–2197
- . American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr. 2003;142:368–372
- Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186–212
- . Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics. 1988;82:309–318
- . Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol. 1991;133:884–899
- . Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up: the Cardiovascular Risk in Young Finns study. Am J Epidemiol. 1994;140:1096–1110
- . The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care. 1985;8:118–124
- . Type 1 diabetic children have abnormal lipid profiles during pubertal years. Pediatr Diabetes. 2001;1:74–81
- Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care. 2006;29:218–225
- Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489–3493
- . Effects of serum lipoproteins and smoking on atherosclerosis in young men and women: the PDAY Research Group: Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 1997;17:95–106
- . Relation of glycohemoglobin and adiposity to atherosclerosis in youth: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 1995;15:431–440
- . Persistence of multiple cardiovascular risk clustering related to Syndrome X from childhood to young adulthood. Arch Intern Med. 1994;154:1842–1847
- Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. [see comments] JAMA. 1997;278:1749–1754
- Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. [see comments] N Engl J Med. 1998;338:1650–1656
- Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277–2283
- . Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation. 2005;112:1486–1493
- Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004;27:530–537
- . Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005;147:544–546
- . Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients: a longitudinal study. Diabetes. 1983;32:20–25
- . Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus. Diabet Med. 1997;14:242–247
- . Clinical practice recommendations 2002. Diabetes Care. 2002;25(Suppl 1):S1–S147
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
- Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292:2585–2590
- Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331–337
- Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005;116:682–688
- Lipid levels in youth with diabetes mellitus: preliminary results from the SEARCH for diabetes in youth study. Diabetes. 2005;54:A569
Support for this study was provided by National Institutes of Health grants T32 DK063687-03 (Dr Maahs), K23RR020038-02 (Dr Nadeau), and K12 DK063722-03 (Dr Wadwa), and Diabetes Education Research Center Grant P30 DK57516.
PII: S0022-3476(06)01026-2
doi: 10.1016/j.jpeds.2006.10.054
© 2007 Mosby, Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 150, Issue 2
, Pages 146-150.e2
, February 2007
